Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study on the Treatment With Taxotere in Combination With Xeloda in Patients With Metastatic Oesophageal Cancer or Cancer in the Cardia Region

NCT00821912 is registered in ClinicalTrials.gov with Karolinska University Hospital as lead sponsor.

NCT NCT00821912
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00821912 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study on the Treatment With Taxotere in Combination With Xeloda in Patients With Metastatic Oesophageal Cancer or Cancer in the Cardia Region
Lead sponsor
Karolinska University Hospital
Phase
Phase 1/2
Overall status
Unknown status
Start date
March 31, 2006
Completion date
September 30, 2013
Enrollment
93 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of the esophagus, gastric cardia carcinoma